Literature DB >> 9581856

Troponin T: a sensitive and specific diagnostic and prognostic marker of myocardial damage.

W Gerhardt1, L Ljungdahl.   

Abstract

Cardiac troponin T (cTnT) in serum is a highly sensitive and specific marker for myocardial damage. Quantitative immunoassays take 9 min. A rapid test (TropT, CardiacT) using plasma detects cTnT concentrations above 0.10 microg/l within 15 min. Both assays are specific for the cardiac isoform. In a study using the maximal values from serial sampling in 502 infarction-suspected patients, we found a diagnostic sensitivity for non-Q- and Q-wave infarctions of 100%, with a specificity of 99%. cTnT has been shown to be a powerful prognostic marker for risk stratification in acute coronary syndromes. In 30-40% of patients with unstable angina, cTnT > or = 0.10 microg/l detects minor myocardial damage (MMD) with poor prognosis. False positives may be found in certain skeletal muscle diseases, such as polymyositis and Duchenne's muscular dystrophy. Constantly increased values in renal failure may be due to uremic cardiomyositis. Even in uremia, a rapid increase of cTnT will indicate acute myocardial damage. We propose a diagnostic strategy based on timed, parallel determinations of myoglobin + cTnT.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9581856     DOI: 10.1016/s0009-8981(97)00251-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Two cases of inflammatory muscle disease presenting with raised serum concentrations of troponin T.

Authors:  J S Hamilton; P C Sharpe
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

2.  The elevated serum S100A8/A9 during acute myocardial infarction is not of cardiac myocyte origin.

Authors:  Chang-Qing Du; Lin Yang; Jie Han; Jian Yang; Xue-Yan Yao; Xiao-Sheng Hu; Shen-Jiang Hu
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 3.  [Cardiac biomarkers in perioperative medicine : significance for noncardiac surgery patients].

Authors:  A Schlitt; I Reindl; H Ebelt; M Buerke; K Werdan
Journal:  Anaesthesist       Date:  2011-08       Impact factor: 1.041

4.  Simultaneous colorimetric determination of acute myocardial infarction biomarkers by integrating self-assembled 3D gold nanovesicles into a multiple immunosorbent assay.

Authors:  Qinli Pu; Xuanhua Yang; Yongcan Guo; Tao Dai; Tingyan Yang; Xinying Ou; Junlong Li; Shangchun Sheng; Guoming Xie
Journal:  Mikrochim Acta       Date:  2019-02-01       Impact factor: 5.833

5.  Is it cardiac involvement mimicking acute myocardial infarction in idiopathic inflammatory myopathy?

Authors:  Yizhi Xiao; Hui Luo; Shiqing Liu; Liping Duan; Yunhui You; Hongjun Zhao; Xiaoxia Zuo
Journal:  Exp Ther Med       Date:  2017-05-11       Impact factor: 2.447

6.  Left Ventricular Hypertrophy and Biomarkers of Cardiac Damage and Stress in Aortic Stenosis.

Authors:  Elliot J Stein; William F Fearon; Sammy Elmariah; Juyong B Kim; Samir Kapadia; Dharam J Kumbhani; Linda Gillam; Brian Whisenant; Nishath Quader; Alan Zajarias; Frederick G Welt; Anthony A Bavry; Megan Coylewright; Robert N Piana; Ravinder R Mallugari; Daniel E Clark; Jay N Patel; Holly Gonzales; Deepak K Gupta; Anna Vatterott; Natalie Jackson; Shi Huang; Brian R Lindman
Journal:  J Am Heart Assoc       Date:  2022-03-18       Impact factor: 6.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.